NEWSMAX @NEWSMAX
Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. https://t.co/yOyrHGnswU — PolitiTweet.org